GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Roche Holding AG (CHIX:ROz) » Definitions » Net Issuance of Debt

Roche Holding AG (CHIX:ROZ) Net Issuance of Debt : CHF9,008 Mil (TTM As of Jun. 2024)


View and export this data going back to 2012. Start your Free Trial

What is Roche Holding AG Net Issuance of Debt?

Net issuance of debt is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive. Roche Holding AG's net issuance of debt for the six months ended in Jun. 2024 was CHF3,756 Mil. Its net issuance of debt for the trailing twelve months (TTM) ended in Jun. 2024 was CHF9,008 Mil.

Roche Holding AG Net Issuance of Debt Historical Data

The historical data trend for Roche Holding AG's Net Issuance of Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Roche Holding AG Net Issuance of Debt Chart

Roche Holding AG Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Net Issuance of Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only -4,403.00 659.00 16,730.00 -5,698.00 5,785.00

Roche Holding AG Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Net Issuance of Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -4,083.00 -1,615.00 533.00 5,252.00 3,756.00

Roche Holding AG Net Issuance of Debt Calculation

This is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive.

Net Issuance of Debt for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was CHF9,008 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Roche Holding AG Net Issuance of Debt Related Terms

Thank you for viewing the detailed overview of Roche Holding AG's Net Issuance of Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Roche Holding AG Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Roche Holding AG (CHIX:ROz) » Definitions » Net Issuance of Debt
Comparable Companies
XSWX:NOVN XSWX:COPN LLY OCSE:NOVO B JNJ ABBV MRK LSE:AZN AMGN PFE XPAR:SAN BMY GILD LSE:GSK TSE:4519 TSE:4568 SHSE:600276 TSE:4578 BIIB XTER:BAYN
Traded in Other Exchanges
RHHVF:USA RHHBY:USA RHHBF:USA ROG N:Mexico ROGz:UK 0TDF:UK 0QQ6:UK 0QOK:UK RHO6:Germany ROG:Switzerland RO:Switzerland
Address
Grenzacherstrasse 124, Basel, CHE, 4070
Website
https://www.roche.com
Roche is a Swiss biopharmaceutical and diagnostic company. The firm's bestselling pharmaceutical products include a variety of oncology therapies from acquired partner Genentech, and its diagnostics group was bolstered by the acquisition of Ventana in 2008. Oncology products account for 50% of pharmaceutical sales, and centralized and point-of-care diagnostics for more than half of diagnostic-related sales.

Roche Holding AG Headlines

No Headlines